We are live on
!
Find out more
PC
Polar Capital Portfolio holdings
AUM
$13.5B
1-Year Est. Return
55.9%
This Fund
S&P 500
This Quarter
Est. Return
+34.87%
1 Year Est. Return
+55.9%
3 Year Est. Return
+127.44%
5 Year Est. Return
+269.08%
10 Year Est. Return
–
AUM
$11.6B
AUM Growth
+$2.27B
(+24%)
Cap. Flow
-$278M
Cap. Flow
% of AUM
-2.4%
Top 10 Holdings %
Top 10 Hldgs %
30.23%
Holding
354
New
65
Increased
75
Reduced
125
Closed
74
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$106M |
| 2 |
Meta Platforms (Facebook)
META
|
+$106M |
| 3 |
PayPal
PYPL
|
+$105M |
| 4 |
XLNX
Xilinx Inc
XLNX
|
+$99.5M |
| 5 |
Ciena
CIEN
|
+$86.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AbbVie
ABBV
|
+$85.6M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$84.6M |
| 3 |
Amazon
AMZN
|
+$72.7M |
| 4 |
Intel
INTC
|
+$72.2M |
| 5 |
RingCentral
RNG
|
+$71.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 36.14% |
| 2 | Healthcare | 19.11% |
| 3 | Financials | 17.15% |
| 4 | Communication Services | 12.94% |
| 5 | Consumer Discretionary | 7.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
NBIS
226
Nebius Group N.V.
NBIS
$47.8B
| $1.55M | 0.01% |
31,011
+2,210
| +8% | +$88.5K |
|
227
HDFC Bank
HDB
$124B
| $1.52M | 0.01% |
66,692
+1,432
| +2% | +$29.4K |
|
228
Afya
AFYA
$1.31B
| $1.5M | 0.01% |
+63,982
| New | +$1.31M |
|
|
ARCE
229
DELISTED
Arco Platform Limited Class A Common Shares
ARCE
| $1.48M | 0.01% |
34,067
+17,361
| +104% | +$823K |
|
230
Itaú Unibanco
ITUB
$93B
| $1.48M | 0.01% |
432,696
-182,904
| -30% | -$593K |
|
|
JOBS
231
DELISTED
51job Inc
JOBS
| $1.46M | 0.01% |
20,348
-2,983
| -13% | -$196K |
|
|
MIXT
232
DELISTED
MIX TELEMATICS LIMITED
MIXT
| $1.31M | 0.01% |
151,510
-101,000
| -40% | -$890K |
|
233
Golub Capital BDC
GBDC
$3.34B
| $1.28M | 0.01% |
110,100
+36,006
| +49% | +$405K |
|
234
Bilibili
BILI
$7.83B
| $1.23M | 0.01% |
26,624
-10,666
| -29% | -$346K |
|
235
QuidelOrtho
QDEL
$1.13B
| $793K | 0.01% |
+3,546
| New | +$556K |
|
236
Webster Financial
WBS
$12.5B
| $765K | 0.01% |
+26,723
| New | +$708K |
|
237
Bank of N.T. Butterfield & Son
NTB
$2.45B
| $687K | 0.01% |
28,170
-1,830
| -6% | -$39.9K |
|
238
Chemed
CHE
$7.1B
| $590K | 0.01% |
1,309
+320
| +32% | +$143K |
|
239
Globus Medical
GMED
$10.9B
| $571K | ﹤0.01% |
11,959
-618,515
| -98% | -$29.8M |
|
240
Encompass Health
EHC
$11B
| $523K | ﹤0.01% |
10,614
+3,142
| +42% | +$170K |
|
|
HRC
241
DELISTED
HILL-ROM HOLDINGS, INC.
HRC
| $521K | ﹤0.01% |
4,744
-485,944
| -99% | -$50.9M |
|
242
Haemonetics
HAE
$3.85B
| $477K | ﹤0.01% |
5,322
+365
| +7% | +$36.9K |
|
243
Repligen
RGEN
$8.1B
| $471K | ﹤0.01% |
+3,810
| New | +$448K |
|
|
RCM
244
DELISTED
R1 RCM Inc. Common Stock
RCM
| $442K | ﹤0.01% |
39,628
-9,500
| -19% | -$97.7K |
|
245
Tandem Diabetes Care
TNDM
$1.3B
| $439K | ﹤0.01% |
4,433
| – | – |
|
|
MGLN
246
DELISTED
Magellan Health Services, Inc.
MGLN
| $428K | ﹤0.01% |
+5,865
| New | +$375K |
|
247
ICU Medical
ICUI
$4.21B
| $410K | ﹤0.01% |
+2,223
| New | +$442K |
|
|
ARNA
248
DELISTED
Arena Pharmaceuticals Inc
ARNA
| $366K | ﹤0.01% |
5,816
-4,622
| -44% | -$254K |
|
249
Option Care Health
OPCH
$3.36B
| $314K | ﹤0.01% |
+22,613
| New | +$299K |
|
250
United Therapeutics
UTHR
$26.2B
| $312K | ﹤0.01% |
+2,575
| New | +$290K |
|
Similar funds
ECM
FAAS
WAM
FS
NIMC
TI
VIM
PS
Polar Capital's Q2 2020 Portfolio in Review
As of Q2 2020, Polar Capital held 354 positions worth $11.6B, up 24% from $9.31B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Polar Capital's Q2 2020 filing shows 65 new, 75 increased, 125 reduced and 74 closed positions. Its largest new stake was TripAdvisor: 3,886,053 shares worth $73.9M. The largest sale was AbbVie, an estimated $85.6M.
By sector, the portfolio is most concentrated in Technology at 36% of assets, up from 36% a quarter earlier, followed by Healthcare and Financials.
- Polar Capital's largest Q2 2020 buy was TripAdvisor: 3,886,053 shares worth $73.9M.
- Polar Capital added most to UnitedHealth in Q2 2020, an estimated $106M increase.
- Polar Capital's biggest Q2 2020 reduction was Bristol-Myers Squibb, cutting an estimated $84.6M.
- Polar Capital fully exited AbbVie in Q2 2020, selling an estimated $85.6M.
- Polar Capital's ten largest holdings make up 30% of its $11.6B portfolio in Q2 2020.
- Polar Capital opened 65 new positions and closed 74 in Q2 2020.
- Polar Capital's portfolio value rose 24% quarter-over-quarter to $11.6B.
Based on Polar Capital's 13F filing for Q2 2020, filed 14 Aug 2020.